Beetroot Supplementation on Non - Alcoholic Fatty Liver Disease Patients.
Nonalcoholic fatty liver disease (NAFLD) has emerged as the one of the most common chronic liver disease worldwide. The pathogenesis of this disease is closely related to obesity and insulin resistance. Beetroot is proposed to have hepatoprotective and hypolipidemic effects due to presence of active...
| Published in: | Current Research in Nutrition & Food Science Vol. 7; no. 1; pp. 96 - 102 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Published: |
Current Research in Nutrition & Food Science
2019
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137062365&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 137062365 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 2347467X KIVQ jtl: Current Research in Nutrition & Food Science issn: 2347467X maglogo: N pubinfo: dt: 2019 vid: 7 iid: 1 pid: 25572 pub: Current Research in Nutrition & Food Science artinfo: ui: 137062365 10.12944/CRNFSJ.7.1.10 137062365 ppf: 96 ppct: 6 formats: fmt: @attributes: type: P tig: atl: Beetroot Supplementation on Non - Alcoholic Fatty Liver Disease Patients. aug: au: SRIVASTAVA, SHIKHA SIDDIQI, ZEBA SINGH, TARUNA BALA, LAKSHMI affil: Department of Food and Nutrition, Era’s Lucknow Medical College, Lucknow, Uttar Pradesh, India. sug: ab: Nonalcoholic fatty liver disease (NAFLD) has emerged as the one of the most common chronic liver disease worldwide. The pathogenesis of this disease is closely related to obesity and insulin resistance. Beetroot is proposed to have hepatoprotective and hypolipidemic effects due to presence of active compound betaine. The aim of this study was to evaluate the therapeutic effect of beetroot supplementation in patients with NAFLD. The present study was case control prospective study in which 40 cases and 40 controls with NAFLD were advised to follow a life style modification along with prescribed treatment but in cases beetroot powder supplementation was also given orally for 12 weeks. The clinical, symptoms, biochemical parameters, and ultrasonography measured were recorded at baseline and after 12 weeks post beetroot supplementation. Beetroot powder supplementation improved clinical symptoms, significant reduction in liver enzymes and lipid profiles, as well as significant reduction in liver size as compared to controls. We did not find any significant effect of beetroot supplementation on fatty liver grade. The supplementation of beetroot powder for 12 weeks showed hepatoprotectective effect in NAFLD subjects. Further long- term studies are recommended to assess beetroot powder supplementation effect on grade of fatty liver. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|